News

BCIL transfers ICMR technology-based Shigella Vaccine to Hilleman Labs

The shigella vaccine, developed by NICED-ICMR is expected to have a huge impact by largely benefiting children living in developing countries and in low-income and middle-income settings.

Read More

May 02, 2019

By : Team ABLE

US FDA approves first vaccine for prevention of dengue disease in endemic regions

Dengvaxia is the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes. The approval was granted to Sanofi Pasteur.

Read More

May 02, 2019

By : Team ABLE

Centre for Promoting Alternatives to Animal Experiments launched by CCMB’s Atal Incubation Centre

The center aims to prioritize investment in human-based, non-animal methodologies in life sciences research in India.

Read More

May 02, 2019

By : Team ABLE

Beckman Coulter introduces Total Laboratory Automation Solution setting new standard for turnaround time

The DxA 5000 delivers rapid and consistent turnaround time, providing the industry's most comprehensive pre-analytical sample quality assessment and improves laboratory efficiency.

Read More

May 02, 2019

By : Team ABLE

UN, other agencies release critical new report on antimicrobial resistance crisis

Recognizing that human, animal, food and environmental health are closely interconnected, the report calls for a coordinated, multisectoral One Health approach.

Read More

Apr 30, 2019

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights